rs4663868

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022817.3(PER2):​c.3111+462G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0918 in 152,268 control chromosomes in the GnomAD database, including 696 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.092 ( 696 hom., cov: 33)

Consequence

PER2
NM_022817.3 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.626

Publications

12 publications found
Variant links:
Genes affected
PER2 (HGNC:8846): (period circadian regulator 2) This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene may increase the risk of getting certain cancers and have been linked to sleep disorders. [provided by RefSeq, Jan 2014]
PER2 Gene-Disease associations (from GenCC):
  • advanced sleep phase syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • advanced sleep phase syndrome 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022817.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022817.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PER2
NM_022817.3
MANE Select
c.3111+462G>A
intron
N/ANP_073728.1O15055-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PER2
ENST00000254657.8
TSL:1 MANE Select
c.3111+462G>A
intron
N/AENSP00000254657.3O15055-1
PER2
ENST00000707129.1
c.3111+462G>A
intron
N/AENSP00000516757.1O15055-1
PER2
ENST00000707130.1
c.3111+462G>A
intron
N/AENSP00000516758.1O15055-1

Frequencies

GnomAD3 genomes
AF:
0.0918
AC:
13973
AN:
152150
Hom.:
696
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0973
Gnomad AMI
AF:
0.0855
Gnomad AMR
AF:
0.0483
Gnomad ASJ
AF:
0.126
Gnomad EAS
AF:
0.0575
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.170
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0848
Gnomad OTH
AF:
0.0833
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0918
AC:
13977
AN:
152268
Hom.:
696
Cov.:
33
AF XY:
0.0961
AC XY:
7156
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0971
AC:
4036
AN:
41558
American (AMR)
AF:
0.0483
AC:
740
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.126
AC:
436
AN:
3472
East Asian (EAS)
AF:
0.0574
AC:
298
AN:
5192
South Asian (SAS)
AF:
0.127
AC:
614
AN:
4830
European-Finnish (FIN)
AF:
0.170
AC:
1802
AN:
10580
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0848
AC:
5767
AN:
68012
Other (OTH)
AF:
0.0819
AC:
173
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
659
1318
1978
2637
3296
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0919
Hom.:
354
Bravo
AF:
0.0817
Asia WGS
AF:
0.0760
AC:
262
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
4.3
DANN
Benign
0.72
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs4663868;
hg19: chr2-239161091;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.